All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel
.
Security |
Imputed Share Price |
Prev Shares |
Current Shares |
Change (Percent) |
Prev Value (USD x1000) |
Current Value (USD x1000) |
Change (Percent) |
AXDX / Accelerate Diagnostics, Inc.
|
|
|
|
|
|
|
|
MRK / Merck & Co., Inc.
|
|
|
|
|
|
|
|
ALDR / Alder BioPharmaceuticals, Inc.
|
|
|
|
|
|
|
|
CLVS / Clovis Oncology Inc
|
|
|
|
|
|
|
|
COG / Cabot Oil & Gas Corp.
|
|
|
|
|
|
|
|
PACB / Pacific Biosciences of California, Inc.
|
|
|
|
|
|
|
|
CHRS / Coherus Oncology, Inc.
|
|
|
|
|
|
|
|
PXD / Pioneer Natural Resources Company
|
|
|
|
|
|
|
|
NBIX / Neurocrine Biosciences, Inc.
|
|
|
|
|
|
|
|
98235T107 / Wright Medical Group N.V.
|
|
|
|
|
|
|
|
PRTK / Paratek Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
NXTM / NxStage Medical, Inc.
|
|
|
|
|
|
|
|
AAAP / Advanced Accelerator Applications S.A
|
|
|
|
|
|
|
|
TSRO / TESARO, Inc.
|
|
|
|
|
|
|
|
MACK / Merrimack Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
/ Oxford Immunotec Global PLC
|
|
|
|
|
|
|
|
QTNT / Quotient Ltd
|
|
|
|
|
|
|
|
OMED / OptMed Inc
|
|
|
|
|
|
|
|
CERS / Cerus Corporation
|
|
|
|
|
|
|
|
SITOQ / SITO Mobile Ltd
|
|
|
|
|
|
|
|
GNCA / Genocea Biosciences Inc
|
|
|
|
|
|
|
|
MDGN / Medgenics, Inc.
|
|
|
|
|
|
|
|
CELGZ / Celgene Corporation Series A Contingent Value Rights
|
|
|
|
|
|
|
|
ROKA / Roka Bioscience, Inc.
|
|
|
|
|
|
|
|
ARAY / Accuray Incorporated
|
|
|
|
|
|
|
|
WKHS / Workhorse Group Inc.
|
|
|
|
|
|
|
|
ADXS / Ayala Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
VNDA / Vanda Pharmaceuticals Inc.
|
|
|
|
|
|
|
|
MASI / Masimo Corporation
|
|
|
|
|
|
|
|
ECA / EnCana Corp.
|
|
|
|
|
|
|
|
YTEN / Yield10 Bioscience, Inc.
|
|
|
|
|
|
|
|
BIIB / Biogen Inc.
|
|
|
|
|
|
|
|
SIEN / Sientra, Inc.
|
|
|
|
|
|
|
|
CELG / Celgene Corp.
|
|
|
|
|
|
|
|
BIOL / BIOLASE, Inc.
|
|
|
|
|
|
|
|
CFRX / ContraFect Corp
|
|
|
|
|
|
|
|
AWH / Aspira Women's Health Inc.
|
|
|
|
|
|
|
|
OPK / OPKO Health, Inc.
|
|
|
|
|
|
|
|
VCYT / Veracyte, Inc.
|
|
|
|
|
|
|
|
QDEL / QuidelOrtho Corporation
|
|
|
|
|
|
|
|
EQT / EQT Corporation
|
|
|
|
|
|
|
|
CORT / Corcept Therapeutics Incorporated
|
|
|
|
|
|
|
|
XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|